MYL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Mylan Inc's research and development for the three months ended in Dec. 2013 was $156 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2013 was $508 Mil.
This is the expense the company spent on research and development.
Mylan Inc Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was 126.486 (Mar. 2013 ) + 111.433 (Jun. 2013 ) + 113.995 (Sep. 2013 ) + 155.909 (Dec. 2013 ) = $508 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Mylan Inc Annual Data
|Research & Development||101||88||102||104||317||275||282||295||401||508|
Mylan Inc Quarterly Data
|Research & Development||71||76||81||94||108||118||126||111||114||156|